EHRA EUROPACE 2013 - European Society of Cardiology
EHRA EUROPACE 2013 - European Society of Cardiology
EHRA EUROPACE 2013 - European Society of Cardiology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
tuesday<br />
posters<br />
tUEsdAy 25 JUnE <strong>2013</strong> - POSTERS MORNING<br />
08:30 - 12:30 Poster session Poster<br />
Poster session 4<br />
Posters must be set up between 08:00 - 08:30, removed between 12:30 - 13:00, to be on display<br />
between 08:30 - 12:30.<br />
The presenter should be available by the poster during the c<strong>of</strong>fee break (10:00 to 11:00) in order to<br />
discuss the research with the audience.<br />
Atrial fibrillation<br />
Dynamics <strong>of</strong> main ECG characteristics after conversion <strong>of</strong> persistent atrial fibrillation and<br />
flutter by new class III antiarrhythmic agent niferidile. P928<br />
Y.U. Yuricheva, S. Sokolov, S. Golitsyn, E. Maykov, N. Mironov, L. Rosenshtraukh, E. Chazov<br />
(Moscow, RU)<br />
Antazoline for rapid termination <strong>of</strong> atrial fibrillation during ablation <strong>of</strong> accessory pathways. P929<br />
R. Piotrowski, T. Krynski, J. Baran, P. Futyma, S. Stec, P. Kulakowski (Warsaw and Rzeszow, PL)<br />
Chronic amiodarone therapy impairs the function <strong>of</strong> the superior sinoatrial node in patients<br />
with atrial fibrillation P930<br />
H.S. Mun, J. Wi, J.S. Uhm, J. Shim, M.H. Lee, H.N. Pak, B. Joung (Seoul, KR)<br />
Hyperuricacidemia as an independent Predictor for Paroxysmal Atrial fibrillation P931<br />
T. Liu, Y. Wu, G. Xu, R. Yuan, G. Li (Tianjin, CN)<br />
Adherence to anticoagulation guidelines in non-valvular atrial fibrillation patients remains<br />
poor despite admission to a tertiary cardiology unit P932<br />
G.S. Kew, M. Tan, T.W. Lim (Singapore, SG)<br />
Heterogenesity <strong>of</strong> breakthrough from right atrium to superior vena cava: implication for safe<br />
superior vena cava isolation P933<br />
A. Suzuki, Y. Yamauchi, A. Yagishita, H. Sato, T. Miyamoto, T. Obayashi, S. Umezawa, A. Niwa,<br />
K. Hirao, K. Aonuma (Kanagawa, Tokyo and Ibaraki, JP)<br />
Mapping and ablation <strong>of</strong> atrial tachycardia after valve surgery plus mini-MAZE procedure P934<br />
Y.M. Xue, X.Z. Zhan, H.T. Liao, X.H. Fang, H. Deng, W. Wei, S.L. Wu (Guangzhou, CN)<br />
long-term success can be achieved with duty-cycled circular multipolar radi<strong>of</strong>requency<br />
ablation after a failed cryoballoon ablation in paroxysmal or persistent atrial fibrillation P935<br />
A. Kiss, E. Nagy-Balo, I. Edes, Z. Csanadi (Debrecen, HU)<br />
transseptal approach for ablation <strong>of</strong> left sided arrhythmias without routine use <strong>of</strong><br />
intracardiac echocardiography P936<br />
M. Jensen-Urstad, H. Bastani, F. Braunschweig, N. Drca, K. Gudmundsson, G. Kenneback,<br />
J. Schwieler, F. Tabrizi, J. Tapanainen, P. Insulander (Stockholm, SE)<br />
Impact <strong>of</strong> atrial fibrosis on wave propagation in human atrial fibrillation. evidence for regional<br />
channel, pivot, slow conduction at delayed enhanced sites P937<br />
A. Jadidi, S. Kim, H. Cochet, H. Lehrmann, C.I. Park, S. Miyazaki, M. Haissaguerre, P. Jais,<br />
T. Arentz (Bad Krozingen, DE; Saint Paul, US; Bordeaux, FR)<br />
Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation.<br />
biochemical assessment <strong>of</strong> collagen type i turnover P938<br />
I.S. Saloustros, E.K. Kallergis, E.K. Kanoupakis, H.M. Mayrakis, S.P. Petousis, M.V. Vernardos,<br />
P.V. Vardas (Heraklion, GR)<br />
138
Change language